1. Home
  2. SBFM vs RVLV Comparison

SBFM vs RVLV Comparison

Compare SBFM & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • RVLV
  • Stock Information
  • Founded
  • SBFM 2006
  • RVLV 2003
  • Country
  • SBFM United States
  • RVLV United States
  • Employees
  • SBFM N/A
  • RVLV N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • RVLV Catalog/Specialty Distribution
  • Sector
  • SBFM Health Care
  • RVLV Consumer Discretionary
  • Exchange
  • SBFM Nasdaq
  • RVLV Nasdaq
  • Market Cap
  • SBFM 6.6M
  • RVLV 1.4B
  • IPO Year
  • SBFM N/A
  • RVLV 2019
  • Fundamental
  • Price
  • SBFM $1.48
  • RVLV $23.81
  • Analyst Decision
  • SBFM Strong Buy
  • RVLV Buy
  • Analyst Count
  • SBFM 1
  • RVLV 14
  • Target Price
  • SBFM $15.00
  • RVLV $26.79
  • AVG Volume (30 Days)
  • SBFM 44.0K
  • RVLV 1.0M
  • Earning Date
  • SBFM 11-04-2025
  • RVLV 11-04-2025
  • Dividend Yield
  • SBFM N/A
  • RVLV N/A
  • EPS Growth
  • SBFM N/A
  • RVLV 38.54
  • EPS
  • SBFM N/A
  • RVLV 0.63
  • Revenue
  • SBFM $36,341,741.00
  • RVLV $1,182,554,000.00
  • Revenue This Year
  • SBFM $32.20
  • RVLV $9.12
  • Revenue Next Year
  • SBFM $32.74
  • RVLV $6.65
  • P/E Ratio
  • SBFM N/A
  • RVLV $37.80
  • Revenue Growth
  • SBFM 19.22
  • RVLV 10.68
  • 52 Week Low
  • SBFM $1.17
  • RVLV $16.80
  • 52 Week High
  • SBFM $3.90
  • RVLV $39.58
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 54.08
  • RVLV 58.90
  • Support Level
  • SBFM $1.45
  • RVLV $22.31
  • Resistance Level
  • SBFM $1.53
  • RVLV $24.29
  • Average True Range (ATR)
  • SBFM 0.07
  • RVLV 0.89
  • MACD
  • SBFM 0.01
  • RVLV 0.05
  • Stochastic Oscillator
  • SBFM 72.22
  • RVLV 84.18

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

Share on Social Networks: